93300-81-3

Basic information

• Product Name: Benzenepropanoic acid, 3-methoxy-a-phenyl-
• CAS NO: 93300-81-3
• Molecular Formula: C16H16O3
• Molecular Weight: 256.301
• Mol File: 93300-81-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzenepropanoic acid, 3-methoxy-a-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenepropanoic acid, 3-methoxy-a-phenyl-(93300-81-3)
• EPA Substance Registry System: Benzenepropanoic acid, 3-methoxy-a-phenyl-(93300-81-3)

Safety Data

• Hazardous Substances Data: 93300-81-3(Hazardous Substances Data)

Upstream product

• 591-31-1 3-methoxy-benzaldehyde 
• 103-82-2 phenylacetic acid 
• 824-98-6 m-methoxybenzyl chloride 
• 24298-04-2 (E)-α-(3'-methoxyphenylmethylene)benzeneacetic acid 

Downstream Products

• 55359-62-1 5-methoxy-2-phenyl-2,3-dihydro-1H-inden-1-one 
• 93273-50-8 methyl β-(m-methoxyphenyl)-α-phenylpropionate 
• 93273-60-0 1-methoxy-3-(2-phenylallyl)benzene 
• 93273-59-7 1-Methoxy-3-((E)-2-phenyl-propenyl)-benzene 
• 93273-51-9 3-(m-methoxyphenyl)-2-phenylpropan-1-ol 
• 93273-57-5 6-methoxy-3,4-dihydronaphthalene 
• 93273-53-1 4-(m-methoxyphenyl)-3-phenylbutyronitrile 
• 76570-03-1 4-(3-methoxyphenyl)-3-phenylbutanoic acid 
• 82525-03-9 6-methoxy-3-phenyl-1-tetralone 
• 93273-54-2 1,3-cis-1-hydroxy-3-phenyl-6-methoxytetralin 
• 93300-82-4 1-(p-hydroxyphenyl)-6-methoxy-3-phenyltetralin 
• 93273-58-6 1-(3-dimethylaminopropyl)-3-phenyl-6-methoxy-3,4-dihydronaphthalene 
• 93273-55-3 1-(o-hydroxyphenyl)-6-methoxy-3-phenyltetralin 
• 93273-52-0 3-(m-methoxyphenyl)-2-phenyl-1-tosyloxypropane 

Relevant articles and documents

GUANIDINE DERIVATIVES AS TRPC MODULATORS

The present invention is directed to guanidine derivatives as inhibitors of transient receptor potential canonical channels (TRPC channels), in particular TRPC3 and/or TRPC6 and/or TRPC7 activity, more particularly TRPC6 activity. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders mediated by TRPC channels (Formula (I))